Walgreens and Rite Aid followed CVS Pharmacy in halting Zantac sales after the FDA flagged a possible carcinogen in the heartburn drug.

Hims & Hers will open its first brick-and-mortar pharmacy in 2020, the telemedicine company announced Sept. 30. 

Below are 10 of the top pharmacy stories published by Becker's Hospital Review in September, beginning with the most popular:

A former pharmacy owner was sentenced to four years in prison Sept. 27 for fraudulently filling and dispensing thousands of prescription medications, including opioids, without a pharmacist license, according to a U.S. Justice Department news release.

Rite Aid plans to focus on its relationship with health insurance plans to help its financial turnaround, rather than attempt another merger, according to Forbes.

CVS Pharmacy has suspended the sale of Zantac and other ranitidine products at its drugstores after the FDA flagged a possible human carcinogen in the popular heartburn drugs.

A 60-word provision in House Speaker Nancy Pelosi's drug-pricing plan could make it impossible for hospitals to get a 340B discount for any drug that Medicare negotiates for, according to STAT.

Pfizer's executive chairman Ian Read will retire at the end of the year, according to The Wall Street Journal.

Avanir Pharmaceuticals agreed to pay $116 million to settle a lawsuit alleging it illegally marketed its drug Nuedexta, according to STAT.

CMS plans to collect pricing and payment information from hospitals participating in the 340B drug discount program, according to a notice issued Sept. 26.